{"id":1002183,"date":"2026-09-09T18:30:34","date_gmt":"2026-09-09T22:30:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/"},"modified":"2026-09-09T18:30:34","modified_gmt":"2026-09-09T22:30:34","slug":"actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","title":{"rendered":"Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>CHICAGO and FORT WORTH, Texas, Sept.  09, 2026  (GLOBE NEWSWIRE) &#8212; Actuate Therapeutics, Inc. (NASDAQ: ACTU) (\u201cActuate\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers, today announced that it will present at the H.C. Wainwright 28<sup>th<\/sup> Annual Global Investment Conference taking place September 14-16, 2026, in New York City. In addition, the management team will be available for one-on-one meetings during the conference.<\/p>\n<p>\n        <strong>Details on the presentation: <\/strong>\n      <\/p>\n<p>\n        <strong>Format<\/strong>: Corporate Presentation<\/p>\n<p>\n        <strong>Date<\/strong>: Monday, September 14, 2026<\/p>\n<p>\n        <strong>Time<\/strong>: 4:00 PM ET<\/p>\n<p>\n        <strong>Webcast Link<\/strong>:<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XMIUw3TVPgMzv4JbR-NYPF_xdv_lYelhiZlkDlwdhw43wIhkO1DP1Vg_gjMMn0XETxkh9_Jrs7cFVKvwbN5e8oQAB7f8embFv8yFZU7HE9y4OF_OWUOEnq7gp4cVlxsaiWOSk0nSIhtQ1JdJcm9Y1LBCDrAOCOW4l1f_qV5iQFFK5YucLFicmUMgkt4PyPGtWp_kNHhixr0zMjuH4plpBHzQWOvPtFAcAanakbLUemqt2KLzrDpC20YDievuLvbYepkdKcZA66zRmfg2mZa5Qy77zh4r0ewt38J1e1_nVFMBr1BXHCzulArIf_lVjnzbQhvVAB98kpK8of2HPluRCCSDmACVq8W1xMjvEboDNmwz9hQFJTvcKPc7sM_IsnVXhtOZj5J8mDe_YFLQUTBPJ-IRUSZJQUTjPHd2OoZOlToa2Xps1xNddFSWSkvFVvkctPsm7RqernNspWCVkk4LComJ2M3LSwa65gAlgoLxvDyNP6B9IjIuG1Q0HBWtiu6p\" rel=\"nofollow\" target=\"_blank\"> click here<\/a><br \/>The webcast of the presentation will be accessible in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MlbpYqR7eClNUWx-hv9YNYETsBf4EVQaqTVSE25TXCQSD15UIQWaDCHkkTNQiwk9DOTih1mjua6Klor32Qxw1KhUrHxPk-KSH794M_75hB4OnRWa74bheFhpeo3Ffh74\" rel=\"nofollow\" target=\"_blank\">Investor section<\/a> of the Actuate website<\/p>\n<p>\n        <strong>About Actuate Therapeutics, Inc.<\/strong>\n      <\/p>\n<p>Actuate is a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers. Actuate\u2019s lead investigational drug, elraglusib (a novel GSK-3\u03b2\u00a0inhibitor), targets molecular pathways in cancer that are involved in promoting tumor growth and resistance to conventional cancer drugs such as chemotherapy through the inhibition of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) and DNA Damage Response (DDR). Elraglusib may also mediate anti-tumor immunity through the regulation of multiple immune checkpoints and immune cell function.<\/p>\n<p>For additional information, please visit the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WoZFP0GCqg4X_IqaYMAL_KBrn4ql5yg_qF-3s-osgLm7wuCwycSkXaw1Nhaqq61Kkhy5ai2fh__oEsjCYSIni-EUfKo7QnMjiYCgjHZ1_scd1srfjBohqIk1SDW_PvesKV_3-89NK1p57xmGffY5nNfa3V5ged1WJSVH8BoUMr3GuuBx-s80w6knTBoUrOgVm8X1noxTQNZntl9ebYwnrWloC26cVccBZh1gUsEg2e8ACUS4WOgTxjvTA9VE6F5DDHL_H3eX4EHvsDphQMC08ajvDbRcR4KHGswDkIygOqqaAdHDkN24mw2XLQpxhyWpycWQzNBnXhDohP-9Gg4x9wQlzZJc0FUdSLMPplgJ8EFBGXDC9KgD2V2A0WcSFd3pQzsy9uNBc7ZPVZVviza0bBfjbwWMGvx1l1bb9FYXzj-D8Q6Aksn_R6brCq85pMWtaguMXsiCDEikW4m27Jav2bMk19q39ePs97-zeQyKFnPMZ9HNRFEWL7aDNXqJEnv_ToC43q9H61sIScZQyoGr5AQhozkbszvAS3ZXCaiBOHb5rleHMjM5YWz_O2Hbj3Wj\" rel=\"nofollow\" target=\"_blank\">www.actuatetherapeutics.com<\/a>\u00a0or follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ohc7Q3CRp1PbacdaZKXYHKr1nv3VmMmWyro9wGXgvNrtZzBC63JRVJQe5Hwm9hv-UaAnQjzaCUFOfuX2AyRpXIyPEXjuAOUM090EWLvvaZSz6kiE-5Atc5tjvDkrQmeni2ZP8tlvmv0UWUuM-Q91ZMOrIqreRLzV9vdBJlMW_z_-b_b_3g_KVP53grBN1m-U5Q6dSWm0BWVQ42akEAqzip2BDvwUIB37vsUT5S8o22gsu-RXm7HaDN-YQ7CZI3HvP_9949K4RwR8TfcSOCU6-EDVizZgwlXUd70OMeFrF_lDeZWRaF-wjjAbrmeGhmmZHPoAdDnMz4y00vcQRhB6s0enhSVr0oXy0LURyI-PnbKf2c3vre5SUDKPnKqthNtrz3QEWpOn2fB62gbQNudZDTFsMajq6-giKNBRAD08BvqUuB5vNhSNpqYEN9XIdoQ1YvntwTGUqtjT3oWd8ZTLac72Olh7PHPivk9fW-Eti6s=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vBhtmVr6Rmii7OuDd2d-Eali1aHKMIsO5soicd64klmfI9mWKVoUqwDwzPbsTgoQw_ksVERGI7cNMH-ORLDJsbKUkCtZ-io6EpPPw9YYgfrqQFP9G979rOQm4OIKYd7kmirUcw7Mx4EFlZsbyU5NlcR2vmRxi-6ULffYFPM8EXhLq5Qs-Y8apiSd8DdMEX0uOQ7zfexwNbaSI89jFAVlny-WONDA3HhnDBQ1xg9l4YRIn7pm4jSYXaU2TsUIHgCA9Cs_T-K1kCb7-ooPgXSX5Atwo0xX1hM_WvNA1Fl23RbPxVOl3TNOOwBfzlmqKTCKeQvJ7VfKrbSdel6zZv9ofppnMV4sm5xVqLQOV_iBFb_OYH8mphF0ODwm_damOT9tB8b571s-fPtM8DZQ2CCLGA3GQR2YjV3oaYoWyHSmYaU=\" rel=\"nofollow\" target=\"_blank\">X,<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DjpJ50DSTcdVMAM_-3VkXw829hjLApNr0J2RXNeuKWySkLsaI9n8gb6zfWgE22T1KzWV4bvbiL7glL75Y4EZWu8xZnGG7sS_EmmXOolXJcFTuqlRoD4_PjGUB_ISSsHInzkN6rqjqdLFN7myWzyU2ngyg4prqG0ffoD_fp57djQqI7A07OKVT1Xaf6nJzqdVSwInOFT7fpucXA1UwWbRTbCIkiMmouoZ6PhL_l4JxsCQcOJ_So_IH0lxAyWhoRRn_5hwuN36gEBbPKBU_B_aVyq2x30faefmrTocmyhXCnkqbtNMhpSD6uoBPRioYPGlK5AdfSx0DJxAyTo6WSeCiPSdGozrNsuLkc0Arznne_Z1voh3Wc9HiZ-GpM75QnWODN1HF2MnSpX36fdxTNqJotJlpm3EUfGw02Vj3SDnDEdlv72GYLGYlSdLr9TLRNnKVXXhbxBpMeLTGxKYPpbTG3MRXMrF5pZc3wFbncFTwNPck0hjndN-Nt123fSU6ZyFJ46h_EWlqcwp2-8p3uIKOQ==\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Mike Moyer<br \/>Managing Director<br \/>LifeSci Advisors, LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DKHnSyYQknD2j0gl3SkMGyaT6dySHvyY0IaiCCLeR2eX3fIJYsw5lnljP3MzSksmMOP_piAoX3wz05r9hmhYGboMwrhiC9cRCT6p1FoX9i04IR1ZlC-vA9t2NQLz4NBpi25b-dnkYYob4Rlv_CV_BpCkc-BcIXxfvms8U0bN9tqk9P0gZVzaZXrQfjXYzgnxb9XI5ayRzIB5L1HslBvh5XJPdk4q4eLKhIxK6dwKjtfR4pAR9xExFQdGLAePbshTmeV5kWSmeOB9zoq_bl80s0NstiGlIO-p5TNzjjX2LAzvcgYf9SO13Ny21xII6GGj\" rel=\"nofollow\" target=\"_blank\">mmoyer@lifesciadvisors.com<\/a><\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Ignacio Guerrero-Ros, Ph.D.<br \/>Russo Partners, LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nIoJtXCuKldmrj1E0FSdem7pwndsIu-NKO_ox_aSblJyvJg-UP6vdQpasvIrWBSs9fVf6uYLmX_UB9Nh2WF3Sbmdr9CqdLdHuvDXxaHGOg5ght-2zRpSo1LOq2oZZOruT3KJvL8HshJ0bCBzdiBhnVKRVTGkUrT1B9ymtXZ7-0k=\" rel=\"nofollow\" target=\"_blank\">Ignacio.guerrero-ros@russopartnersllc.com<\/a><br \/>(858) 717-2310<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDAyMCM3ODI1NjYzIzIyOTM1Mzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDlhZDg1NTktYTQ1NC00M2E4LWE0N2YtNWRlMWM4ZWU1MmM2LTEzMDUwODgtMjAyNi0wOS0wOS1lbg==\/tiny\/Actuate-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHICAGO and FORT WORTH, Texas, Sept. 09, 2026 (GLOBE NEWSWIRE) &#8212; Actuate Therapeutics, Inc. (NASDAQ: ACTU) (\u201cActuate\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers, today announced that it will present at the H.C. Wainwright 28th Annual Global Investment Conference taking place September 14-16, 2026, in New York City. In addition, the management team will be available for one-on-one meetings during the conference. Details on the presentation: Format: Corporate Presentation Date: Monday, September 14, 2026 Time: 4:00 PM ET Webcast Link: click hereThe webcast of the presentation will be accessible in the Investor section of the Actuate website About Actuate Therapeutics, Inc. Actuate is a clinical-stage biopharmaceutical company focused on &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1002183","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHICAGO and FORT WORTH, Texas, Sept. 09, 2026 (GLOBE NEWSWIRE) &#8212; Actuate Therapeutics, Inc. (NASDAQ: ACTU) (\u201cActuate\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers, today announced that it will present at the H.C. Wainwright 28th Annual Global Investment Conference taking place September 14-16, 2026, in New York City. In addition, the management team will be available for one-on-one meetings during the conference. Details on the presentation: Format: Corporate Presentation Date: Monday, September 14, 2026 Time: 4:00 PM ET Webcast Link: click hereThe webcast of the presentation will be accessible in the Investor section of the Actuate website About Actuate Therapeutics, Inc. Actuate is a clinical-stage biopharmaceutical company focused on &hellip; Continue reading &quot;Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-09T22:30:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDAyMCM3ODI1NjYzIzIyOTM1Mzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference\",\"datePublished\":\"2026-09-09T22:30:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\"},\"wordCount\":248,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyNDAyMCM3ODI1NjYzIzIyOTM1Mzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\",\"name\":\"Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyNDAyMCM3ODI1NjYzIzIyOTM1Mzg=\",\"datePublished\":\"2026-09-09T22:30:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyNDAyMCM3ODI1NjYzIzIyOTM1Mzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyNDAyMCM3ODI1NjYzIzIyOTM1Mzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk","og_description":"CHICAGO and FORT WORTH, Texas, Sept. 09, 2026 (GLOBE NEWSWIRE) &#8212; Actuate Therapeutics, Inc. (NASDAQ: ACTU) (\u201cActuate\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers, today announced that it will present at the H.C. Wainwright 28th Annual Global Investment Conference taking place September 14-16, 2026, in New York City. In addition, the management team will be available for one-on-one meetings during the conference. Details on the presentation: Format: Corporate Presentation Date: Monday, September 14, 2026 Time: 4:00 PM ET Webcast Link: click hereThe webcast of the presentation will be accessible in the Investor section of the Actuate website About Actuate Therapeutics, Inc. Actuate is a clinical-stage biopharmaceutical company focused on &hellip; Continue reading \"Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-09T22:30:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDAyMCM3ODI1NjYzIzIyOTM1Mzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference","datePublished":"2026-09-09T22:30:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/"},"wordCount":248,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDAyMCM3ODI1NjYzIzIyOTM1Mzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","name":"Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDAyMCM3ODI1NjYzIzIyOTM1Mzg=","datePublished":"2026-09-09T22:30:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDAyMCM3ODI1NjYzIzIyOTM1Mzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDAyMCM3ODI1NjYzIzIyOTM1Mzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/actuate-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1002183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1002183"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1002183\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1002183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1002183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1002183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}